| 证券代码 | CVRS.A |
| 证券名称 | Corindus Vascular Robotics Inc |
| 证券类型 | 美股 |
| 上市场所 | 美国证券交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2015-05-29 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | Cowen and Company, LLC,Stifel, Nicolaus & Company, Incorporated |
| 货币单位 | USD |
| 公司名称 | Corindus Vascular Robotics, Inc. |
| 注册地址 | 美国内华达州 |
| 办公地址 | 309 Waverley Oaks Rd., Suite 105, Waltham, Massachusetts, USA |
| 成立日期 | 2011-05-04 |
| 董事会主席 | Jeffrey C. Lightcap |
| 公司属地 | United States 美国 |
| 公司网址 | www.corindus.com |
| 电话 | +1 (508) 653-3335 |
| 传真 | +1 (508) 232-6000 |
| 公司简介 | Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The company's FDA cleared CorPath System is the first medical device that offers interventional cardiologists PCI procedure control from a radiation protective interventional cockpit. With the CorPath System, Corindus Vascular Robotics brings robotic precision to PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications through improper stent placement. |